Published in Drug Week, March 16th, 2007
Genetic abnormalities are common in many human cancers and their precursors, including esophageal adenocarcinoma and Barrett’s esophagus. Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) have been proposed as possible chemoprevention against esophageal adenocarcinoma and Barrett’s esophagus.
A study of 243 patients with Barrett’s esophagus followed up for 10 years by Patricia Galipeau and colleagues from the Fred Hutchinson Cancer Research Center, Seattle looked at various genetic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week